Alembic Pharmaceuticals Limited operates as an independent, publicly traded corporate entity listed on major Indian stock exchanges rather than being a wholly owned subsidiary of a single parent conglomerate. The company was originally demerged from its historic parent organization, Alembic Limited, to create a specialized, dedicated vehicle focused exclusively on global pharmaceutical formulations, active pharmaceutical ingredients, and research-driven healthcare solutions, while Alembic Limited retains a significant strategic equity investment in the firm.